Shantell Laketa Heiber

Array ( [id] => 1286815 [patent_doc_number] => 06632438 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-10-14 [patent_title] => 'Recombinant poxvirus cytomegalovirus, compositions, and uses' [patent_app_type] => B2 [patent_app_number] => 09/916963 [patent_app_country] => US [patent_app_date] => 2001-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 82 [patent_figures_cnt] => 97 [patent_no_of_words] => 67694 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/632/06632438.pdf [firstpage_image] =>[orig_patent_app_number] => 09916963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5887932 [patent_doc_number] => 20020012664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-31 [patent_title] => 'Anti-CCR2 antibodies and methods of use therefor' [patent_app_type] => new [patent_app_number] => 09/905848 [patent_app_country] => US [patent_app_date] => 2001-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 18095 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20020012664.pdf [firstpage_image] =>[orig_patent_app_number] => 09905848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1469511 [patent_doc_number] => 06406865 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-06-18 [patent_title] => 'Method of inhibiting interaction of cells bearing CCR2 by Anti-CCR2 amino-terminal domain antibodies' [patent_app_type] => B2 [patent_app_number] => 09/905847 [patent_app_country] => US [patent_app_date] => 2001-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 40 [patent_no_of_words] => 17932 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/406/06406865.pdf [firstpage_image] =>[orig_patent_app_number] => 09905847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6095258 [patent_doc_number] => 20020051782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'Anti-CCR2 antibodies and methods of use therefor' [patent_app_type] => new [patent_app_number] => 09/905849 [patent_app_country] => US [patent_app_date] => 2001-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 18098 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20020051782.pdf [firstpage_image] =>[orig_patent_app_number] => 09905849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5999682 [patent_doc_number] => 20020028436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'Anti-CCR2 antibodies and methods of use therefor' [patent_app_type] => new [patent_app_number] => 09/905835 [patent_app_country] => US [patent_app_date] => 2001-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 18099 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028436.pdf [firstpage_image] =>[orig_patent_app_number] => 09905835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1241069 [patent_doc_number] => 06682892 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-27 [patent_title] => 'Method for treating herpes viruses' [patent_app_type] => B2 [patent_app_number] => 09/904065 [patent_app_country] => US [patent_app_date] => 2001-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 14705 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/682/06682892.pdf [firstpage_image] =>[orig_patent_app_number] => 09904065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730093 [patent_doc_number] => 20030186283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Herpes zinc finger motifs' [patent_app_type] => new [patent_app_number] => 10/332795 [patent_app_country] => US [patent_app_date] => 2003-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5707 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186283.pdf [firstpage_image] =>[orig_patent_app_number] => 10332795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1071575 [patent_doc_number] => 06841157 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-11 [patent_title] => 'Production of chimeric human papillomavirus' [patent_app_type] => utility [patent_app_number] => 10/332553 [patent_app_country] => US [patent_app_date] => 2001-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 5206 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/841/06841157.pdf [firstpage_image] =>[orig_patent_app_number] => 10332553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6846327 [patent_doc_number] => 20030165494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Anti-CCR2 antibodies and methods of use therefor' [patent_app_type] => new [patent_app_number] => 09/898513 [patent_app_country] => US [patent_app_date] => 2001-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18082 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20030165494.pdf [firstpage_image] =>[orig_patent_app_number] => 09898513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6554957 [patent_doc_number] => 20020164353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Replication-defective adenovirus human type 5 recombinant as a vaccine carrier' [patent_app_type] => new [patent_app_number] => 09/897170 [patent_app_country] => US [patent_app_date] => 2001-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9406 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20020164353.pdf [firstpage_image] =>[orig_patent_app_number] => 09897170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1468954 [patent_doc_number] => 06406694 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-18 [patent_title] => 'Anti-CCR2 antibodies' [patent_app_type] => B1 [patent_app_number] => 09/896309 [patent_app_country] => US [patent_app_date] => 2001-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 40 [patent_no_of_words] => 17922 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/406/06406694.pdf [firstpage_image] =>[orig_patent_app_number] => 09896309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1593989 [patent_doc_number] => 06491915 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-12-10 [patent_title] => 'Anti-CCR2 antibodies and methods of use therefor' [patent_app_type] => B2 [patent_app_number] => 09/895723 [patent_app_country] => US [patent_app_date] => 2001-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 40 [patent_no_of_words] => 18054 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/491/06491915.pdf [firstpage_image] =>[orig_patent_app_number] => 09895723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5951276 [patent_doc_number] => 20020006610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-17 [patent_title] => 'Mixed cell diagnostic systems' [patent_app_type] => new [patent_app_number] => 09/895911 [patent_app_country] => US [patent_app_date] => 2001-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19079 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20020006610.pdf [firstpage_image] =>[orig_patent_app_number] => 09895911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7390136 [patent_doc_number] => 20040037847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'ASSAYS FOR COMPOUNDS THAT MODULATE RHADINO VIRUS LANA ACTION IN TRANS ON A UNIT OF RHADINO VIRUS DNA TO MEDIATE EFFICIENT EPISOME PERSISTENCE' [patent_app_type] => new [patent_app_number] => 09/894273 [patent_app_country] => US [patent_app_date] => 2001-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13934 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20040037847.pdf [firstpage_image] =>[orig_patent_app_number] => 09894273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5967905 [patent_doc_number] => 20020090610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-11 [patent_title] => 'Compositions and methods for the diagnosis and treatment of herpes simplex virus infection' [patent_app_type] => new [patent_app_number] => 09/894998 [patent_app_country] => US [patent_app_date] => 2001-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39547 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20020090610.pdf [firstpage_image] =>[orig_patent_app_number] => 09894998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6541827 [patent_doc_number] => 20020110566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-15 [patent_title] => 'Human papilloma virus treatment' [patent_app_type] => new [patent_app_number] => 09/891823 [patent_app_country] => US [patent_app_date] => 2001-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10433 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20020110566.pdf [firstpage_image] =>[orig_patent_app_number] => 09891823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 996312 [patent_doc_number] => 06913751 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-05 [patent_title] => 'Recombinant avian herpesvirus useful in vaccine production' [patent_app_type] => utility [patent_app_number] => 09/881457 [patent_app_country] => US [patent_app_date] => 2001-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11174 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/913/06913751.pdf [firstpage_image] =>[orig_patent_app_number] => 09881457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1336535 [patent_doc_number] => 06589532 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-08 [patent_title] => 'Papilloma viruses, means for the detection thereof and therapy for diseases caused thereby' [patent_app_type] => B1 [patent_app_number] => 09/786454 [patent_app_country] => US [patent_app_date] => 2001-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5489 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/589/06589532.pdf [firstpage_image] =>[orig_patent_app_number] => 09786454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 415109 [patent_doc_number] => 07279306 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-09 [patent_title] => 'Stable (fixed) forms of viral capsid proteins, and viral capsid protein fusions, preferably papillomavirus L1 proteins, and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/332037 [patent_app_country] => US [patent_app_date] => 2001-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8343 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/279/07279306.pdf [firstpage_image] =>[orig_patent_app_number] => 10332037 [rel_patent_id] =>[rel_patent_doc_number] =>)